Charles River offers clients new database for pediatric oncology research
Charles River has granted its clients the ability to conduct preclinical cancer research using ITCC-P4’s collection of 400 annotated pediatric cancer models.
Stay updated with breaking news from Accelerate Cures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Charles River has granted its clients the ability to conduct preclinical cancer research using ITCC-P4’s collection of 400 annotated pediatric cancer models.
Recently established regulatory guidelines make testing for pediatric indications a necessary step in oncology research and development ...
This Week in Washington: President Biden announces ending date of COVID-19 PHE, House begins investigations into COVID-19 origins; State of the Union scheduled for Feb. 7...
Lawmakers on the Senate Judiciary Committee are not wasting time revisiting a package of bills that aim to increase competition to brand drugs.
12/08/22 Clinical Leader Newsletter